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Induction of Labor: Review of 
Pros, Cons, and Controversies
Donald Morrish and Iffath Abbasi Hoskins
Abstract
Although induction of labor (IOL) has increased over the years, corresponding 
improvements in perinatal outcomes have not occurred. IOL may result in increased 
risks for mother and baby, due to factors like gestational age (GA), Bishop score of 
cervix, and the methods used. Failed IOL resulting in increased cesarean sections 
may be due to unripe cervix, inadequate Pitocin use, and incorrect patient choice. 
Medically indicated IOL does not require awaiting 39 weeks GA. Nonmedically 
indicated IOL prior to 39 weeks GA may result in neonatal morbidity. Patients at 
39 weeks GA can be induced electively and need not await labor. Cervical ripening 
methods include vaginal, oral, or IV medications and can be administered as outpa-
tients rather than in hospitals, in order to decrease financial and time constraints. 
Ethical issues regarding indications, GA, choice of agent, location of cervical ripen-
ing, and failed IOL can have an impact on healthcare resources.
Keywords: induction of labor, evidence-based management
1. Introduction
Induction of labor (IOL) is defined as the initiation of uterine contractions to 
achieve a vaginal birth before the onset of spontaneous labor. Although IOL rates, 
including those of elective inductions, have almost doubled, the perinatal outcomes 
have not improved proportionately [1].
While IOL can occur at any GA after 20 weeks, in general this intervention is 
reserved for those occurring at early term or late term. The definitions for the dif-
ferent gestational ages are shown in Table 1 [2].
Definition GAs
Preterm <37 weeks GA
Term 40 weeks
Early term 37 weeks 0 day–38 weeks 6 days
Full term 39 weeks 0 day–40 weeks 6 days
Late term 41 weeks 0 day–41 weeks 6 days
Post term ≥42 weeks
Table 1. 
Definitions and gestational ages (GAs).
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If women are in spontaneous labor, in general, 96% will enter active phase of 
labor by 15 hours from the onset of contractions. If the duration of latent phase is 
prolonged, the rate of cesarean section (C/S) increases, as does the complication 
rate (e.g., postpartum hemorrhage, chorioamnionitis). However, >40% of patients 
with latent phase ≥18 hours will deliver vaginally [3].
If labor is induced, the vast majority of women will deliver vaginally. The failed 
IOL rate is 12–15% especially if the cervix is unripe at the onset of the intervention [4].
IOL should be considered as an appropriate option if it is based upon evidence-
based medicine, optimizes maternal and fetal outcomes, and is cost-effective.
2. Timing of IOL
There are no clear recommendations regarding the timing of eIOL in early- and 
late-term pregnancies.
Awaiting 39 weeks GA is not required if there is a medical indication for 
IOL. Nonmedically indicated early-term IOL should not occur prior to 39 weeks 
GA. Because non-respiratory morbidity is also increased, simply documenting fetal 
lung maturity is inadequate to justify this intervention, even in suboptimally dated 
pregnancies [5].
Timing the IOL at 39 weeks GA vs. expectantly managing the pregnancy till 
onset of labor but before 42 weeks GA is a desirable option.
Bailit [6] studied 31,000 expectantly managed primiparas and found that there 
was a 5% rate of developing maternal hypertension after 39 weeks GA. Increased 
rates of fetal macrosomia and placental insufficiency also occurred. The risks for 
fetal death were also increased (Table 2).
Keulen et al. [7] described results of a study wherein IOL at 41 weeks GA was 
compared to expectant management until 42 weeks GA. Although there were no 
significant differences in the C/S rates between the two groups (10.8% in both), 
there were fewer adverse perinatal outcomes (5-minute Apgar score <7, meconium 
aspiration) in IOL group vs. in the expectant management group (1.7 vs. 3.1%).
Gulmezoglu et al. [8] reported on 9383 patients from 22 trials and found that 
expectant management, until onset of labor up to 42 weeks GA, resulted in a higher 
C/S rate (180/1000 women) vs. 160/1000 women with IOL and an increase in 
all-cause perinatal deaths [9] vs. 1 in the IOL group. The number needed to treat 
to benefit (NNTB) with IOL in order to prevent 1 perinatal death was 410 (95% CI 
322–1492).
Sinkey et al. [10] reported on a Monte Carlo microsimulation model regarding 
eIOL at 39 weeks or expectant management (EM) with IOL for standard medical or 
obstetrical indications or at 41 weeks if undelivered. eIOL at 39 weeks resulted in 
fewer maternal and neonatal risks vs. EM with IOL at 41 weeks among undelivered 
All pregnancies/10,000 Low-risk pregnancies/10,000
GA
39 weeks 3–4 1
40 weeks 4–5 2
41 weeks 4–7 3
42 weeks 7–12 4
Table 2. 
Risk of fetal death at ≥39 weeks GA.
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patients. C/S rates were statistically significantly higher in the EM arm (35.9 vs. 
13.9%). When patients had an unfavorable cervix, eIOL at 39 weeks resulted in 
fewer C/S vs. EM (8.0 vs. 26.1%; p < 0.01). While there were no differences in 
maternal mortality between the two groups (0% eIOL vs. EM 0.01%, p = 0.32), the 
maternal morbidity in EM was 21.2 vs. 16.5% p < 0.01. The still birth rate in eIOL 
was 0 vs. 0.13% in EM (p < 0.0003). The neonatal deaths were 0.12% in eIOL vs. 
0.25% in EM (p < 0.03), and neonatal morbidity was 9.4% in eIOL vs. 12.1% in EM 
(p < 0.01). Thus, preference modeling calculations revealed that 39-week eIOL was 
the preferred option over EM.
Grobman et al. [4] studied the perinatal consequences of IOL at 39 weeks GA 
among 6106 low-risk nulliparous women from 412 hospitals in an RCT parallel 
group, unmasked trial. Neonatal death or severe neonatal complications occurred in 
4.3% in IOL group vs. 5.4% in the EM group (RR 0.80; 95% CI 0.64–1.00). The IOL 
group had an 18.6% C/S rate vs. 22.2% in EM group (RR 0.84; 95% CI 0.76–0.93). 
The rate of hypertension/preeclampsia was 9.1% in the IOL group vs. 14.1% in the 
EM group. They concluded that 1 C/S may be avoided for every 28 deliveries among 
low-risk nulliparas who undergo elective IOL at 39 weeks GA. They recommended 
that if eIOL option is not used, the patients should be informed of the higher likeli-
hoods of developing hypertension/preeclampsia and of requiring a C/S when EM 
option is pursued.
3. Bishop score
The Bishop score is the most commonly used method for evaluating the ripeness 
of the cervix, which in turn helps predict the likelihood of a successful IOL, i.e., 
vaginal birth. This calculation was originally intended to help predict the likelihood 
of going into labor for multiparous women who were at term. Currently, the Bishop 
score is used to assess the likelihood of a successful vaginal delivery in both nulliparas 
and multiparas who are at term. The score includes assessment of cervical dilation, 
effacement, consistency, position, and station of the presenting part. A low score 
≤5 suggested that spontaneous labor would not ensue within the next 2–3 weeks. 
A higher score (≥6–7) indicated a likelihood of labor occurring within the next 
7–10 days. In the setting of a low Bishop score, the likelihood of a failed induction 
(i.e., need for C/S) is 25%. Thus, when an IOL is planned, every attempt should be 
made to first “ripen” the cervix, i.e., increase the Bishop score to a value ≥7.
4. Techniques
Misoprostol, Cervidil, Foley balloon (with or without oxytocin), amniotomy, 
and stripping membranes are all accepted techniques for IOL. Each of those options 
has inherent risks and complications.
Misoprostol is cheap, is stable at room temperature, and can be used both orally 
and rectally even in resource poor settings. Although it is not FDA approved for 
this indication, it is a commonly chosen option. Wallstrom et al. [11] studied 4002 
pts who received liquid misoprostol every 2 hours vs. receiving a rectal or oral 
tablet. The C/S rate was 17 vs. 26% with tablets, and there were no adverse perinatal 
outcomes (low Apgar scores, pH values, PPH). This option can be used when more 
rapid and reliable absorption of the agent is desired.
Cervidil (dinoprostone) is the only FDA-approved intervention for cervical ripen-
ing but is more costly than misoprostol. Tsikouris et al. [12] compared 50 μg miso-
prostol vs. 3 mg dinoprostone in two vaginal doses 6 hours apart, followed as needed, 
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with oxytocin for labor induction in low-risk post term (>40 weeks GA) with unfa-
vorable cervix (Bishop score ≤6). They found that women in the dinoprostone group 
were more likely to need a second vaginal dose in order to proceed to labor (43.4 vs. 
21.5% in miso group, p = 0.01). Both groups had equivalent rates of successful IOL 
(91.6% with miso vs. 85.8% with dinoprostone). Although, there was a shorter time 
to delivery with misoprostol vs. with dinoprostone (11 vs. 14.1 hours, p < 0.001), this 
group demonstrated a higher rate of tachysystole miso (16.8 vs. 4.0%, p = 0.007).
Bauer et al. [9] reported that in an RCT in 180 multiparas randomized to simul-
taneous use of Foley balloon with oxytocin vs. sequential use of oxytocin given 
after the Foley balloon was removed, there was a statistically increased likelihood 
of delivery within 24 hours with simultaneous use (87.8% in simultaneous group 
vs. 73.3% in sequential group; p = 0.02). This group also had a significantly shorter 
induction to delivery interval and greater cervical dilation at balloon expulsion. The 
mode of delivery and intra-amniotic infection rates were similar. Thus, the simulta-
neous option is preferable.
Fruhman et al. [13] conducted an RCT on 140 women with Bishop score ≤6, 
receiving either tension in 30 minutes increments on the Foley balloon catheter or 
no tension. The outcomes (vaginal delivery within 24 hours and C/S rates) were 
similar in the two groups, thus concluding that this intervention was not needed.
Smyth et al. [14] reported the results of a Cochrane review regarding the effec-
tiveness and safety of amniotomy. Although amniotomy resulted in a 20-minute 
decrease in the first stage of labor and a lower rate of C/S, these were not statisti-
cally significant. Thus, amniotomy should not be a routine part of labor manage-
ment but should only be considered if clinical indications exist, such as the need for 
internal fetal scalp electrode in order to obtain reliable fetal heart tracings.
Amniotic membrane stripping results in release of prostaglandins and is a safe, 
effective and inexpensive method to induce labor [15]. When performed at 38–40 
weeks GA, it increases the likelihood of spontaneous labor, reduces the need for 
additional induction methods, and decreases the likelihood of pregnancies going 
post term. GBS prophylaxis is not indicated for this intervention. However, there 
is no date regarding hepatitis B or HIV transmission to fetus with this option, and 
patients should be informed accordingly.
5. Requirements for IOL
All patients should have accurate dating, ideally performed by reliance on last 
menstrual period (LMP) which has >90% accuracy if regular periods or by an 
early first trimester ultrasound, which has >99% accuracy. If there is a discrepancy 
between the two options, the best GA estimate should be utilized (Table 3).
6. Complications
The use of Foley balloon is associated with increased likelihood of infections 
and injury to the cervix and vagina. Additionally, malpresentations have occurred 
after vertex presentation at insertion of the Foley balloon. Injury to fetus (bruising/
necrosis of ear, face, arm) have also been reported.
Oxytocin can be administered by low-dose, intermediate-dose, or high-dose 
protocols. Low dose is 3 mu/min, intermediate dose is 4–6 mu/min, and high 
dose is >6 mu/min. The low-dose option results in longer duration of IOL. High 
dose results in increased rates of tachysystole with or without FHR abnormalities. 
Intermediate-dose protocol is preferred because it results in lower C/S rates vs. the 
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other two protocols and there is no associated increase in the induction to delivery 
time. Complications are hyperstimulation/tachysystole and can result in fetal 
compromise or uterine rupture. Water intoxication (low urine output and fluid 
retention) has also been reported. AF embolism although rare can occur in the third 
stage of labor, after placental separation.
Concerns about autism in neonates after maternal oxytocin use have not been 
proven. Current evidence does not identify a causal relationship between oxytocin 
for IOL and autism. The ACOG recommends against any changes in current prac-
tices regarding the use of this agent [16].
A research group from the SW Autism Research & Resource Center (SARRC) 
surveyed mothers with affected children and found that the rates were no different 
in groups that used medications (oxytocin + epidural) in labor vs. those who did 
not. Thus, the authors concluded that exposure to L&D drugs was not an indepen-
dent risk factor for autism/autism spectrum disorders (Table 4).
7. Setting of IOL
At present, the vast majority of IOL occur within hospital settings. These 
interventions require the use of significant resources (lab studies, labor rooms, fetal 
heart rate and contraction monitoring, RN involvement, analgesia). In general, 
the cervical ripening process (prior to the onset of labor) requires approximately 
8–12 hours. This intervention increases the overall duration of the patient’s admis-
sion in the hospital. In a Cochrane review of outpatient cervical ripening, 5003 term, 
low-risk women were pooled from 34 RCTs. IOL, either totally in an outpatient set-
ting or sending the patient home shortly after initial treatment had been initiated in 
GA Discrepancy Action
First trimester (using CRL)
<8 weeks 6 days >5 days Use u/s calculated dates
9 weeks 0 day–13 weeks 6 days >7 days Use u/s calculated dates
Second trimester (using BPD, HC, AC, FL)
14 weeks 0 day–15 weeks 6 days >7 days Use u/s calculated dates
16 weeks 0 day–21 weeks 6 days >10 days Use u/s calculated dates
22 weeks 0 day–27 weeks 6 days >14 days Use u/s calculated dates
Third trimester (using BPD, HC, AC, FL)
≥28 weeks 0 day >21 days Use u/s calculated dates*
*Least accurate for redating, considering IUGR.
Table 3. 
Dating of pregnancy using LMP and ultrasound.
Autism/ASD+ Autism/ASD−
49 104
No exposure 12% 28% NS
Yes exposure 88% 72% NS
Table 4. 
Exposure to L&D drugs (oxytocics, epidural).
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hospital setting, was deemed safe and satisfactory [17]. The most preferred method 
for this intervention was nonpharmacologic, i.e., cervical Foley balloon. Patient 
acceptance and satisfaction were not markedly different with this option.
8. Labor management
Spong et al. [3] recommend that for all obstetrical care, the focus should be to 
minimize perinatal morbidity and decrease the chance of a C/S. If maternal and 
fetal condition remains reassuring, nonintervention in the latent phase of labor 
is paramount. A latent phase up to 24 hours and the use of oxytocin for at least 
12–18 hours after rupture of membranes and with adequate contractions should be 
obtained before declaring that IOL has failed (Table 5).
9. Cost implications
At present, approximately 25% of the 4 million annual US births undergo 
IOL. These currently occur at varying GAs and are due to clinically accepted 
indications. Elective IOL in all low-risk pregnant women would result in a strain 
on current resources and would take away from the availability of these resources 
from clinically indicated scenarios (spontaneous labor). Therefore, if this option 
is chosen, there should be maximum communication and coordination between 
healthcare providers and hospital personnel along with the patient and her support 
personnel. Grobman [18] reported that existing opinions regarding increased costs 
related to IOL may be due to the belief that there is increased resource utilization 
and possible adverse outcomes such as C/S. When IOL is compared to spontaneous 
labor, observational studies lean toward increased costs. However, when IOL costs 
are compared to expectant management, the costs appear to be similar, but there 
are improved perinatal outcomes. Additionally, there is minimal to no information 
regarding outpatient costs due to expectant management.
10. Ethics
In a statement about ethical decision-making, the ACOG recommends that 
the major principles guiding IOL should involve respect for patient’s autonomy, 
Failed IOL Failure to obtain cervical dilation after 24 hours of strong/regular contractions with 
oxytocin use and rupture of membranes
First-stage 
arrest
≥6 cm dilation with rupture of membranes
≥4 hours adequate uterine contractions
Second-stage 
arrest
No descent/rotation after
≥4 hours in nullips with epidural
≥3 hours in nullips without epidural
≥3 hours in multips with epidural
≥2 hours in multips without epidural
Table 5. 
Definition/duration of failed inductions and arrest disorders.
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beneficence, nonmaleficence, and justice [19]. As has been shown in the discus-
sions within this document, at every step of the process of IOL, the clinician must 
make every effort to respect the patient’s autonomy (i.e., self-rule, whereby she 
can apply her own moral principles) while acknowledging the limitations of her 
ability to fully understand and therefore participate in such medically complex 
decision-making for herself and her baby. This concept, along with the other ethical 
principles stated herein, creates the moral foundation of informed consent, which 
must be integrated into the fabric of direct patient care.
11. Conclusions
Given the option, over 50% of women with uncomplicated pregnancies would 
elect to be induced [20]. However, IOL is associated with increased utilization of 
labor and delivery resources. One way to help address these issues is to preferentially 
choose outpatient settings for some interventions (e.g., membrane sweeping or 
cervical ripening agents), in order to decrease clogging up scant inpatient resources. 
Creating a model similar to a VBAC calculator could be beneficial in identifying the 
likelihood of success with eIOL and of neonatal morbidity.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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